About this trial
The purpose of this study is to compare the efficacy, prognosis, health economics of different treatment modalities of mid-low rectal cancer in different centers in China, and to conduct cost utility analysis (CUA) on the treatment process of rectal cancer to explore the best treatment modality that meets the actual need of medical units in each region and at each level. The investigators hope to provide evidence-based medical suggestions for medical quality control of rectal cancer and revision of clinical guidelines, and provides a source of decision making for medical management and medical insurance.
Eligibility criteria
Qualifiers
pathologically confirmed rectal adenocarcinoma
located within 12cm below the anal verge
Disqualifiers
diagnosed with distant metastasis
multiple primary colorectal cancers
history of previous malignant tumors
Pregnant or lactating women
Trial design
Treatments tested in this trial
- Registry study, no specific intervention